Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Digitoxose
Cat. No.:
OB0425LY-335
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Digitoxose as a part of cardiac glycosides, digitoxose is relevant in the study of heart failure treatments, assisting in the development of drugs that positively affect cardiac contractility.
Synonyms:
527-52-6; 2,6-Dideoxy-D-ribo-hexose; 2,6-Dideoxy-D-altrose; (3S,4R,5R)-3,4,5-Trihydroxyhexanal
CAS No.:
527-52-6
Compound CID:
94168
Formula:
C6H12O4
Formula Weight:
148.16
Specification
Target:
Biochemical assay reagents
Pathway:
Others
Storage:
Storage at -20°C.
Applications:
Digitoxosecan be used in glucose-stimulated insulin release tests and diabetes research.
